Chagas disease: Ortho Clinical Diagnostics launches New VITROS®Anti-T. cruzi Assay
by Press Release from Outbreak News Today on (#3ZH7N)
Assay Is Now Available in Mexico and Countries That Accept CE Mark Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, Monday announced the introduction of its next-generation Anti-T. cruzi assay, with CE Mark approval and approval for use in Mexico. Ortho's VITROS(R) Anti-T. cruzi assay offers best-in-class sensitivity which is key to the early detection ["]
The post Chagas disease: Ortho Clinical Diagnostics launches New VITROS(R)Anti-T. cruzi Assay appeared first on Outbreak News Today.